NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI, Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval - Durango Downtown
NRx Pharmaceuticals (NRx) (NASDAQ:NRXP) announced today it has validated the first commercial formulation of ZYESAMI™ (aviptadil) for intravenous use,
WSM Admin
